• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧驱动的乳腺癌血管生成机制与治疗靶点:一篇叙述性综述

Hypoxia-driven angiogenesis in breast cancer mechanisms and therapeutic targets: a narrative review.

作者信息

Obeagu Emmanuel Ifeanyi

机构信息

Department of Biomedical and Laboratory Science, Africa University, Zimbabwe.

出版信息

Ann Med Surg (Lond). 2025 May 20;87(7):4246-4254. doi: 10.1097/MS9.0000000000003411. eCollection 2025 Jul.

DOI:10.1097/MS9.0000000000003411
PMID:40851994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12369738/
Abstract

Breast cancer remains a significant global health challenge, with hypoxia playing a crucial role in its progression. Hypoxia, defined as reduced oxygen availability, is a hallmark of solid tumors and particularly influences the tumor microenvironment in breast cancer. Under hypoxic conditions, tumors activate a variety of molecular responses that promote survival, including the stabilization of hypoxia-inducible factors (HIFs). These transcription factors regulate the expression of pro-angiogenic genes, such as vascular endothelial growth factor (VEGF), which drive angiogenesis and support tumor growth. However, the vasculature formed under hypoxic conditions is often dysfunctional, contributing to tumor progression, metastasis, and resistance to therapies. This review explores the mechanisms by which hypoxia drives angiogenesis in breast cancer, emphasizing the roles of HIFs, VEGF signaling, and metabolic reprogramming. Angiogenesis, a critical process for tumor survival and growth, is primarily mediated by the induction of VEGF under hypoxic conditions. VEGF acts on endothelial cells to promote blood vessel formation, ensuring the tumor receives sufficient oxygen and nutrients. However, the vessels formed are typically leaky and inefficient, exacerbating the hypoxic environment and perpetuating a cycle of tumor progression. The metabolic reprogramming that occurs in hypoxic tumor cells, such as the shift toward glycolysis (the Warburg effect), also plays a pivotal role in sustaining angiogenesis. The resulting acidic conditions further enhance VEGF production and endothelial cell migration, supporting continued tumor growth and metastasis.

摘要

乳腺癌仍然是一项重大的全球健康挑战,缺氧在其进展过程中起着关键作用。缺氧被定义为氧气供应减少,是实体瘤的一个标志,对乳腺癌的肿瘤微环境有特别影响。在缺氧条件下,肿瘤会激活多种促进生存的分子反应,包括缺氧诱导因子(HIFs)的稳定。这些转录因子调节促血管生成基因的表达,如血管内皮生长因子(VEGF),后者驱动血管生成并支持肿瘤生长。然而,在缺氧条件下形成的脉管系统往往功能失调,促进肿瘤进展、转移和对治疗的抵抗。本综述探讨了缺氧驱动乳腺癌血管生成的机制,强调了HIFs、VEGF信号传导和代谢重编程的作用。血管生成是肿瘤生存和生长的关键过程,主要由缺氧条件下VEGF的诱导介导。VEGF作用于内皮细胞以促进血管形成,确保肿瘤获得足够的氧气和营养。然而,形成的血管通常渗漏且效率低下,加剧了缺氧环境并使肿瘤进展循环持续。缺氧肿瘤细胞中发生的代谢重编程,如向糖酵解(瓦伯格效应)的转变,在维持血管生成方面也起着关键作用。由此产生的酸性条件进一步增强VEGF的产生和内皮细胞迁移,支持肿瘤持续生长和转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea0/12369738/5ff9e1984092/ms9-87-4246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea0/12369738/63ff22d3ee9a/ms9-87-4246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea0/12369738/5ff9e1984092/ms9-87-4246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea0/12369738/63ff22d3ee9a/ms9-87-4246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea0/12369738/5ff9e1984092/ms9-87-4246-g002.jpg

相似文献

1
Hypoxia-driven angiogenesis in breast cancer mechanisms and therapeutic targets: a narrative review.缺氧驱动的乳腺癌血管生成机制与治疗靶点:一篇叙述性综述
Ann Med Surg (Lond). 2025 May 20;87(7):4246-4254. doi: 10.1097/MS9.0000000000003411. eCollection 2025 Jul.
2
Angiogenesis and Resistance Mechanisms in Glioblastoma: Targeting Alternative Vascularization Pathways to Overcome Therapy Resistance.胶质母细胞瘤中的血管生成与耐药机制:靶向替代血管生成途径以克服治疗耐药性
Curr Pharm Des. 2025 Jul 22. doi: 10.2174/0113816128367551250703122830.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications.缺氧诱导因子 1α 和血管内皮生长因子在多形性胶质母细胞瘤中的作用:超越病理意义的系统评价。
Oncol Res. 2024 Jul 17;32(8):1239-1256. doi: 10.32604/or.2024.052130. eCollection 2024.
5
Limning of HIF-2 and HIF-3 in the Tumor Microenvironment: Developing Concepts for the Treatment of Hypoxic Cancer.肿瘤微环境中HIF-2和HIF-3概述:缺氧癌症治疗的发展概念
Curr Mol Med. 2024 May 17. doi: 10.2174/0115665240303179240427071748.
6
Downregulation of LATS1/2 Drives Endothelial Senescence-Associated Stemness (SAS) and Atherothrombotic Lesion Formation.LATS1/2的下调驱动内皮细胞衰老相关干性(SAS)和动脉粥样血栓形成病变的形成。
bioRxiv. 2025 Jun 21:2025.06.19.660635. doi: 10.1101/2025.06.19.660635.
7
Design, synthesis, and evaluation of antitumor activity in Pseudolaric acid B Azole derivatives: Novel and potent angiogenesis inhibitor via regulation of the PI3K/AKT and MAPK mediated HIF-1/VEGF signaling pathway.设计、合成及评价苯并唑衍生物对白头翁酸 B 的抗肿瘤活性:通过调控 PI3K/AKT 和 MAPK 介导的 HIF-1/VEGF 信号通路的新型强效血管生成抑制剂。
Eur J Med Chem. 2024 Nov 15;278:116813. doi: 10.1016/j.ejmech.2024.116813. Epub 2024 Aug 30.
8
Dll4-Notch signaling in regulation of tumor angiogenesis.Dll4-Notch 信号通路在肿瘤血管生成调控中的作用。
J Cancer Res Clin Oncol. 2014 Apr;140(4):525-36. doi: 10.1007/s00432-013-1534-x. Epub 2013 Oct 10.
9
Integrated single-cell and transcriptomic analysis of bone marrow-derived metastatic neuroblastoma reveals molecular mechanisms of metabolic reprogramming.骨髓源性转移性神经母细胞瘤的单细胞与转录组学整合分析揭示代谢重编程的分子机制。
Sci Rep. 2025 Aug 5;15(1):28519. doi: 10.1038/s41598-025-13626-8.
10
USP6NL knockdown suppresses colorectal cancer progression by inducing CASP9-Mediated apoptosis and disrupting FOXC2/SNAI1-Driven EMT and angiogenesis.USP6NL基因敲低通过诱导半胱天冬酶9介导的凋亡以及破坏FOXC2/SNAI1驱动的上皮-间质转化和血管生成来抑制结直肠癌进展。
Funct Integr Genomics. 2025 Jul 11;25(1):153. doi: 10.1007/s10142-025-01663-5.

本文引用的文献

1
Lymphocyte infiltration in breast cancer: A promising prognostic indicator.乳腺癌中的淋巴细胞浸润:一个有前景的预后指标。
Medicine (Baltimore). 2024 Dec 6;103(49):e40845. doi: 10.1097/MD.0000000000040845.
2
Therapeutic Opportunities in Breast Cancer by Targeting Macrophage Migration Inhibitory Factor as a Pleiotropic Cytokine.通过靶向巨噬细胞移动抑制因子这一多功能细胞因子探索乳腺癌的治疗新机遇
Breast Cancer (Auckl). 2024 Sep 6;18:11782234241276310. doi: 10.1177/11782234241276310. eCollection 2024.
3
Breastfeeding's protective role in alleviating breast cancer burden: a comprehensive review.
母乳喂养在减轻乳腺癌负担方面的保护作用:一项综述
Ann Med Surg (Lond). 2024 Mar 5;86(5):2805-2811. doi: 10.1097/MS9.0000000000001914. eCollection 2024 May.
4
Exploring the profound link: Breastfeeding's impact on alleviating the burden of breast cancer - A review.探讨深远关联:母乳喂养缓解乳腺癌负担的影响——综述。
Medicine (Baltimore). 2024 Apr 12;103(15):e37695. doi: 10.1097/MD.0000000000037695.
5
Exploring neutrophil functionality in breast cancer progression: A review.探讨中性粒细胞在乳腺癌进展中的功能:综述。
Medicine (Baltimore). 2024 Mar 29;103(13):e37654. doi: 10.1097/MD.0000000000037654.
6
Breast cancer: A review of risk factors and diagnosis.乳腺癌:危险因素与诊断综述。
Medicine (Baltimore). 2024 Jan 19;103(3):e36905. doi: 10.1097/MD.0000000000036905.
7
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer.乳腺癌靶向治疗和免疫治疗的临床进展。
Mol Cancer. 2023 Jul 6;22(1):105. doi: 10.1186/s12943-023-01805-y.
8
Understanding Breast Cancer Aggressiveness and Its Implications in Diagnosis and Treatment.了解乳腺癌的侵袭性及其在诊断和治疗中的意义。
J Clin Med. 2023 Feb 9;12(4):1375. doi: 10.3390/jcm12041375.
9
Epigenetic Regulation in Breast Cancer: Insights on Epidrugs.乳腺癌中的表观遗传调控:对表观遗传药物的见解
Epigenomes. 2023 Feb 18;7(1):6. doi: 10.3390/epigenomes7010006.
10
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer.免疫检查点调节剂、代谢重编程与三阴性乳腺癌细胞可塑性之间的串扰。
Curr Oncol. 2022 Sep 23;29(10):6847-6863. doi: 10.3390/curroncol29100540.